BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31513558)

  • 1. State Strategies to Address Opioid Use Disorder Among Pregnant and Postpartum Women and Infants Prenatally Exposed to Substances, Including Infants with Neonatal Abstinence Syndrome.
    Kroelinger CD; Rice ME; Cox S; Hickner HR; Weber MK; Romero L; Ko JY; Addison D; Mueller T; Shapiro-Mendoza C; Fehrenbach SN; Honein MA; Barfield WD
    MMWR Morb Mortal Wkly Rep; 2019 Sep; 68(36):777-783. PubMed ID: 31513558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing access to quality care for pregnant and postpartum people with opioid use disorder: Coordination of services, provider awareness and training, extended postpartum coverage, and perinatal quality collaboratives.
    Ellick KL; Kroelinger CD; Chang K; McGown M; McReynolds M; Velonis AJ; Bronson E; Riehle-Colarusso T; Pliska E; Akbarali S; Mueller T; Dronamraju R; Cox S; Barfield WD
    J Subst Use Addict Treat; 2024 Jan; 156():209208. PubMed ID: 37939904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Sustainability of State-Led Action Plans for the Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Syndrome Initiative Learning Community, 2018-2021.
    Kroelinger CD; Ellick KL; Levecke M; Rice ME; Mueller T; Akbarali S; Pliska E; Ko JY; Cox S; Barfield WD
    J Womens Health (Larchmt); 2023 May; 32(5):503-512. PubMed ID: 37159557
    [No Abstract]   [Full Text] [Related]  

  • 4. Prenatal Substance Exposure and Neonatal Abstinence Syndrome: State Estimates from the 2016-2020 Transformed Medicaid Statistical Information System.
    West KD; Ali MM; Blanco M; Natzke B; Nguyen L
    Matern Child Health J; 2023 Dec; 27(Suppl 1):14-22. PubMed ID: 37219692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal Abstinence Syndrome.
    Jansson LM; Patrick SW
    Pediatr Clin North Am; 2019 Apr; 66(2):353-367. PubMed ID: 30819342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transitioning Care Approach for Neonatal Opioid Withdrawal Syndrome and Neonatal Abstinence Syndrome.
    Perez C
    Crit Care Nurs Clin North Am; 2024 Jun; 36(2):223-233. PubMed ID: 38705690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal opioid exposure by likelihood of exposure and risk to prenatal development: Medicaid-covered births in Wisconsin, 2010-2019.
    Berger LM; Durrance C; Ehrenthal D; Kim H; Kuo HH; Pac J
    Sci Adv; 2024 May; 10(19):eadg9674. PubMed ID: 38718116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demographics, Birth Parameters, and Social Determinants of Health Among Opioid-Exposed Mother-Infant Dyads Affected by Neonatal Abstinence Syndrome in Pennsylvania, 2018-2019.
    Decker CM; Mahar M; Howells CL; Ma ZQ; Goetz CT; Watkins SM
    Matern Child Health J; 2023 Dec; 27(Suppl 1):34-43. PubMed ID: 37243807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and Costs of Neonatal Abstinence Syndrome Among Infants With Medicaid: 2004
    Winkelman TNA; Villapiano N; Kozhimannil KB; Davis MM; Patrick SW
    Pediatrics; 2018 Apr; 141(4):. PubMed ID: 29572288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Care Experiences of Persons With Perinatal Opioid Use: A Qualitative Study.
    Blair LM; Ashford K; Gentry L; Bell S; Fallin-Bennett A
    J Perinat Neonatal Nurs; 2021 Oct-Dec 01; 35(4):320-329. PubMed ID: 34726648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal Abstinence Syndrome in East Tennessee: Characteristics and Risk Factors among Mothers and Infants in One Area of Appalachia.
    Erwin PC; Meschke LL; Ehrlich SF; Lindley LC
    J Health Care Poor Underserved; 2017; 28(4):1393-1408. PubMed ID: 29176103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses: Analysis of ICD-10-CM Transition, 2013-2017.
    Ko JY; Hirai AH; Owens PL; Stocks C; Patrick SW
    Hosp Pediatr; 2021 Aug; 11(8):902-908. PubMed ID: 34321311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Services Use Among Children With Prenatal Substance Exposure or Neonatal Abstinence Syndrome.
    West KD; Ali MM; Natzke B; Nguyen L
    Psychiatr Serv; 2024 Mar; 75(3):287-290. PubMed ID: 37711020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation.
    Reddy UM; Davis JM; Ren Z; Greene MF;
    Obstet Gynecol; 2017 Jul; 130(1):10-28. PubMed ID: 28594753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion of Sex and Gender Differences in U.S. State Action Plans for Opioid Use and Opioid Use Disorder.
    Goss T; Esguerra J; Newman C; Patrick J; Templeton K
    J Womens Health (Larchmt); 2024 Mar; 33(3):275-282. PubMed ID: 38064491
    [No Abstract]   [Full Text] [Related]  

  • 16. Growing together: Optimization of care through quality improvement for the mother/infant dyad affected by perinatal opioid use.
    Miller MR; MacMillan KDL
    Semin Perinatol; 2024 Apr; 48(3):151907. PubMed ID: 38702266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardization of State Definitions for Neonatal Abstinence Syndrome Surveillance and the Opioid Crisis.
    Chiang KV; Okoroh EM; Kasehagen LJ; Garcia-Saavedra LF; Ko JY
    Am J Public Health; 2019 Sep; 109(9):1193-1197. PubMed ID: 31318590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postpartum Treatment for Substance Use Disorder Among Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Substance Exposure.
    Faherty LJ; Heins S; Kranz AM; Stein BD
    Womens Health Rep (New Rochelle); 2021; 2(1):163-172. PubMed ID: 34235503
    [No Abstract]   [Full Text] [Related]  

  • 19. Managing the Mother-Baby Dyad Affected by Substance Disorder: A Statewide Quality Collaborative Initiative.
    Spence K; Williams A
    Mo Med; 2024; 121(3):212-219. PubMed ID: 38854608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal Abstinence Syndrome: Leveraging Health Information Technology to Develop a Data-Driven National Policy Approach.
    Jilani SM; Giroir BP
    Public Health Rep; 2020; 135(2):173-176. PubMed ID: 32027558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.